EUROFINS CLINICAL GENETICS UK LIMITED
Get an alert when EUROFINS CLINICAL GENETICS UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1K
0% vs 2024
Net assets
£49K
+16.7% vs 2024
Employees
5
-16.7% lowest in 3 filed years
Profit before tax
-£208K
+64.3% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £2,055,000 | £1,478,000 | £1,750,000 | +18.4% | |
| Operating profit | -£2,684,000 | -£545,000 | -£182,000 | +66.6% | |
| Profit before tax | -£2,705,000 | -£582,000 | -£208,000 | +64.3% | |
| Net profit | -£2,746,000 | -£563,000 | -£243,000 | +56.8% | |
| Cash | £48,000 | £1,000 | £1,000 | 0% | |
| Total assets less current liabilities | £876,000 | £85,000 | £84,000 | -1.2% | |
| Net assets | £431,000 | £42,000 | £49,000 | +16.7% | |
| Equity | £431,000 | £42,000 | £49,000 | +16.7% | |
| Average employees | 14 | 6 | 5 | -16.7% | |
| Wages | £1,051,000 | £334,000 | £246,000 | -26.3% | |
| Directors' remuneration | £81,000 | £18,000 | £25,000 | +38.9% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -130.6% | -36.9% | -10.4% | |
| Net margin | -133.6% | -38.1% | -13.9% | |
| Return on capital employed | -306.4% | -641.2% | -216.7% | |
| Current ratio | 0.99x | 0.70x | 0.96x | |
| Interest cover | -52.63x | -12.11x | -4.55x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- EUROFINS CLINICAL GENETICS UK LIMITED 2023-12-01 → present
- EUROFINS BIOMNIS UK LIMITED 2017-07-03 → 2023-12-01
- BIOMNIS LABORATORIES UK LIMITED 2010-06-08 → 2017-07-03
Audit & accounting basis
- Accounting basis
- FRS 101 'Reduced Disclosure Framework'
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Constantin
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that it is appropriate to prepare the financial statements on a going concern basis. There is no known reason or uncertainty that the Company cannot continue as a going concern.”
Significant events
- “Subsequent to 31 December 2025, geopolitical tensions in the Middle East escalated on 28 February 2026, including military actions and related economic sanctions involving the United States, Iran, Israel, and certain other countries in the region (the "Conflict").”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 14 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GANDERTON, Laura Jayne | Secretary | 2023-01-20 | — | — |
| O'SULLIVAN, John Mark | Director | 2025-04-14 | Feb 1963 | Irish |
| VINE, Sam Francis | Director | 2024-12-16 | May 1990 | British |
Show 14 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| KAYE, Gavin Mark | Secretary | 2010-06-08 | 2016-03-23 |
| MILES, Sonia | Secretary | 2022-04-01 | 2023-01-20 |
| MILLS, Alice Irene | Secretary | 2016-03-23 | 2022-03-31 |
| CAMPBELL, Mark William | Director | 2010-10-01 | 2012-06-15 |
| CARTON, Olivier Daniel | Director | 2010-06-08 | 2013-02-04 |
| CHIPPERFIELD, Simon Charles | Director | 2010-06-08 | 2012-06-15 |
| GUIAVARCH, Pierre-Yves | Director | 2010-06-08 | 2013-02-04 |
| HARTNETT, Michael Thomas | Director | 2023-03-31 | 2024-03-31 |
| KOHLI, Amit | Director | 2017-06-19 | 2018-09-28 |
| MILLS, Alice Irene | Director | 2016-03-23 | 2022-05-06 |
| O'SULLIVAN, John Mark | Director | 2013-02-04 | 2023-03-31 |
| VAN DORP, Rob | Director | 2024-03-25 | 2025-03-18 |
| WATTS, Michael Robert | Director | 2022-05-06 | 2024-12-16 |
| WOLER, Charles | Director | 2013-02-04 | 2016-11-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Eurofins Scientific S.E. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-30 | Active |
Filing timeline
Last 20 of 77 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-12-01 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-23 | AA | accounts | Accounts with accounts type full | |
| 2025-12-31 | SH01 | capital | Capital allotment shares | |
| 2025-11-10 | RP01CS01 | confirmation-statement | Replacement filing of confirmation statement with made up date | |
| 2025-08-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-19 | AA | accounts | Accounts with accounts type full | |
| 2025-04-16 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-03 | CH01 | officers | Change person director company with change date | |
| 2024-12-16 | TM01 | officers | Termination director company with name termination date | |
| 2024-12-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-11-22 | SH01 | capital | Capital allotment shares | |
| 2024-08-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-05-17 | AA | accounts | Accounts with accounts type full | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-27 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-19 | SH01 | capital | Capital allotment shares | |
| 2023-12-01 | CERTNM | change-of-name | Certificate change of name company | |
| 2023-08-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-21 | AA | accounts | Accounts with accounts type full | |
| 2023-03-31 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.